Lucinactant for the prevention of respiratory distress syndrome in premature infants

ISSN： 1751-2433

Source： Expert Review of Clinical Pharmacology, Vol.6, Iss.2, 2013-03, pp. : 115-121

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lucinactant in neonatal respiratory distress syndrome: profile report

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 21, Iss. 10, 2005-10 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Lucinactant: a novel synthetic surfactant for the treatment of respiratory distress syndrome

By Donn Steven M

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 3, 2005-03 ,pp. : 329-334

Informa Healthcare

Access to resources Recommend Favorite

Nitric oxide for the treatment of preterm infants with respiratory distress syndrome

By Dani Carlo Pratesi Simone

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 1, 2013-01 ,pp. : 97-103

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy for Prevention and Treatment of Acute Respiratory Distress Syndrome: Current and Experimental Approaches

By Bosma Karen J. Taneja Ravi Lewis James F.

Drugs, Vol. 70, Iss. 10, 2010-07 ,pp. : 1255-1282

Adis International

Access to resources Recommend Favorite

Pharmacotherapy of acute respiratory distress syndrome

By Santos CC dos Slutsky AS Chant C

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 875-888

Informa Healthcare

Access to resources Recommend Favorite